The LTC Innovation Blog

Summary: This article explores the imminent release of a feature within FrameworkLTC aiding pharmacies in making informed decisions on biosimilar substitutions, accompanied by an overview of biologic drugs, their classifications, and the regulatory landscape surrounding their substitution. Table of Contents

Parkinson's disease is among the most complex conditions to face — not only for patients but also for caregivers and other health and pharmacy professionals involved in the field of long-term care. The disease's degenerative nature means that by the time post-acute and LTC facilities get involved, patients are at Parkinson's most difficult stage.